Burney Co. lowered its stake in Johnson & Johnson (NYSE:JNJ – Free Report) by 4.4% in the course of the 2nd quarter, in keeping with the corporate in its most up-to-date submitting with the Securities & Trade Fee. The institutional investor owned 29,684 shares of the corporate’s inventory after promoting 1,353 shares in the course of the quarter. Burney Co.’s holdings in Johnson & Johnson had been price $4,339,000 as of its most up-to-date SEC submitting.
Different hedge funds and different institutional traders have additionally made adjustments to their positions within the firm. Christopher J. Hasenberg Inc purchased a brand new stake in Johnson & Johnson within the first quarter price $31,000. Vermillion & White Wealth Administration Group LLC purchased a brand new stake in shares of Johnson & Johnson within the 4th quarter price about $44,000. Disciplined Fairness Administration Inc. bought a brand new stake in shares of Johnson & Johnson in the course of the 4th quarter valued at about $45,000. MFA Wealth Advisors LLC purchased a brand new place in shares of Johnson & Johnson within the 2nd quarter valued at about $43,000. Lastly, Grayhawk Funding Methods Inc. grew its place in Johnson & Johnson by 528.6% within the fourth quarter. Grayhawk Funding Methods Inc. now owns 308 shares of the corporate’s inventory price $48,000 after buying a further 259 shares within the final quarter. Institutional traders personal 69.55% of the corporate’s inventory.
Analyst Rankings Modifications
Quite a lot of analysts lately issued studies on JNJ shares. TD Securities lowered their worth goal on Johnson & Johnson from $195.00 to $185.00 in a analysis report on Thursday, July 18th. TD Cowen dropped their worth goal on shares of Johnson & Johnson from $195.00 to $185.00 and set a “purchase” score for the corporate in a analysis word on Thursday, July 18th. Sanford C. Bernstein elevated their worth goal on shares of Johnson & Johnson from $161.00 to $171.00 in a analysis report on Thursday, July 18th. Daiwa America lowered Johnson & Johnson from a “strong-buy” score to a “maintain” score in a analysis report on Tuesday, July twenty third. Lastly, StockNews.com upgraded Johnson & Johnson from a “purchase” score to a “strong-buy” score in a report on Friday, August sixteenth. Seven analysts have rated the inventory with a maintain score, six have given a purchase score and one has given a robust purchase score to the corporate. In keeping with knowledge from MarketBeat.com, Johnson & Johnson at present has a consensus score of “Average Purchase” and a consensus worth goal of $173.21.
Learn Our Newest Inventory Report on JNJ
Johnson & Johnson Inventory Up 0.2 %
Johnson & Johnson inventory opened at $164.60 on Friday. Johnson & Johnson has a 1-year low of $143.13 and a 1-year excessive of $165.83. The inventory has a market capitalization of $396.14 billion, a price-to-earnings ratio of 10.24, a PEG ratio of two.63 and a beta of 0.52. The corporate has a debt-to-equity ratio of 0.44, a present ratio of 1.07 and a fast ratio of 0.85. The enterprise has a fifty day shifting common worth of $155.01 and a 200-day shifting common worth of $153.38.
Johnson & Johnson (NYSE:JNJ – Get Free Report) final introduced its quarterly earnings knowledge on Wednesday, July seventeenth. The corporate reported $2.82 earnings per share for the quarter, beating analysts’ consensus estimates of $2.71 by $0.11. Johnson & Johnson had a web margin of 46.34% and a return on fairness of 36.60%. The agency had income of $22.45 billion for the quarter, in comparison with analyst estimates of $22.33 billion. Throughout the identical interval within the earlier yr, the corporate earned $2.80 earnings per share. The enterprise’s quarterly income was up 4.3% in comparison with the identical quarter final yr. Equities analysis analysts forecast that Johnson & Johnson will put up 10.07 EPS for the present fiscal yr.
Johnson & Johnson Dividend Announcement
The agency additionally lately introduced a quarterly dividend, which will probably be paid on Tuesday, September tenth. Buyers of document on Tuesday, August twenty seventh will probably be given a dividend of $1.24 per share. The ex-dividend date of this dividend is Tuesday, August twenty seventh. This represents a $4.96 dividend on an annualized foundation and a yield of three.01%. Johnson & Johnson’s dividend payout ratio is presently 30.92%.
Johnson & Johnson Firm Profile
Johnson & Johnson, along with its subsidiaries, researches, develops, manufactures, and sells numerous merchandise within the healthcare discipline worldwide. The corporate’s Progressive Drugs section provides merchandise for numerous therapeutic areas, equivalent to immunology, together with rheumatoid arthritis, psoriatic arthritis, inflammatory bowel illness, and psoriasis; infectious illnesses comprising HIV/AIDS; neuroscience, consisting of temper problems, neurodegenerative problems, and schizophrenia; oncology, equivalent to prostate most cancers, hematologic malignancies, lung most cancers, and bladder most cancers; cardiovascular and metabolism, together with thrombosis, diabetes, and macular degeneration; and pulmonary hypertension comprising pulmonary arterial hypertension by way of retailers, wholesalers, distributors, hospitals, and healthcare professionals for prescription use.
Featured Articles
Need to see what different hedge funds are holding JNJ? Go to HoldingsChannel.com to get the newest 13F filings and insider trades for Johnson & Johnson (NYSE:JNJ – Free Report).
Obtain Information & Rankings for Johnson & Johnson Day by day – Enter your e mail handle under to obtain a concise each day abstract of the newest information and analysts’ scores for Johnson & Johnson and associated corporations with MarketBeat.com’s FREE each day e mail e-newsletter.
